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Background:  Cannabis  is  the  most  popular  illicit  drug  in the  world,  but the  process  of  its diffusion  through
the  population  has rarely  been  studied.  The  unfolding  of  the  tobacco  epidemic  was  accompanied  by  a
shift  in  the  educational  gradient  of  users  across  generations.  As  a consequence,  cannabis  may  show  the
same  pattern  of widening  social  inequalities.  We  test  the  diffusion  hypotheses  that  a  positive  value  in
older  cohorts  – the more  educated  experimenting  more  – shifts  to a negative  one  in younger  cohorts  –
the  more  educated  experimenting  less,  ﬁrst for males  and  then  females.
Methods:  Three  nationwide  subsamples  (18–64  years  old) of representative  surveys  conducted  in France
(n =  21,818),  Germany  (n = 7887)  and  USA  (n = 37,115)  in  2009–2010  recorded  age  at  cannabis  experimen-
tation  (i.e.,  ﬁrst use),  educational  level,  gender,  and age.  Cumulative  prevalence  of experimentation  was
plotted  for  three  retrospective  cohorts  (50–64,  35–49,  18–34  years  old  at data  collection)  and  multivariate
time-discrete  logistic  regression  was  computed  by gender  and  generation  to model  age  at  experimen-
tation  adjusted  on  age  at data  collection  and  educational  level.  This  latter  was  measured  according  to
four  categories  derived  from  the  International  Standard  Classiﬁcation  of  Education  (ISCED)  and  a  relative
(rather than  absolute)  index  of  education.
Results:  The  ﬁndings  demonstrate  a consistent  pattern  of  evolution  of the prevalence,  gender ratio  and
educational  gradient  across  generations  and  countries  that  support  the hypothesis  of  an “epidemic”  of
cannabis  experimentation  that  mimics  the epidemic  of  tobacco.
Conclusion:  We  provide  evidence  for a cannabis  epidemic  model  similar  to  the  tobacco  epidemic  model.
In  the  absence  of clues  regarding  the  future  of cannabis  use,  our ﬁndings  demonstrate  that  the gender gap
is decreasing  and, based  on  the epidemic  model,  suggest  that  we  may  expect  widening  social  inequalities
in  cannabis  experimentation  if  cannabis  use  decreases  in  the  future.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-NDntroduction
Cannabis is the most popular illegal drug used worldwide, and
he USA is the country which has the highest level of use (EMCDDA,
012). In Europe, as much as 23.7% of those aged 15–64 years old
eported having smoked cannabis during their life (about 80.5
illions of people), 6.8% (23 millions) reported last year use, and
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el.: +33 156 06 20 98.
E-mail address: Stephane.legleye@ined.fr (S. Legleye).
ttp://dx.doi.org/10.1016/j.drugpo.2014.07.002
955-3959/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
3.6% (12 millions) reported last month use (EMCDDA, 2012). There
is a huge variation in the last year use prevalence across countries
(from 0.4% to 14.3%). Past-year cannabis use has been shown to
be highest in young adults and decreasing sharply in older ages
in Europe and abroad (Vicente, Olszewski, & Matias, 2008). With
regard to frequency of use, available data suggest that the majority
of cannabis frequent users concentrate in individuals aged up to
35 years.Cultivation of cannabis (or “hemp” or “marijuana”) has been
known for centuries in western countries, and used mainly for
industrial purposes. In the USA, the use of cannabis as a psy-
choactive substance began in the middle of the 19th century, but
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ecreational use of the drug became associated primarily with
exican-American immigrant workers and the African-American
azz musician community in the beginning of the 20th century
Becker, 1963). It was recognized as an intoxicant in the late 1920s.
he federal government voted the “Marihuana Tax Act” in 1937
hat led to its interdiction (Peretti-Watel, Beck, & Legleye, 2007),
ut its use nevertheless became popular in the 1950s. Cannabis
ntered Europe as a medicine in the middle of the 19th century
Lords, 1998), but its recreational use was anecdotal before the
ate 1960s and limited to some small groups like “Le club des
aschischins” (that comprised celebrities such as the poets Baude-
aire and Theophile Gautier, the writers Balzac and Flaubert, and
he painter Delacroix) in France (Gautier, 2011). The mass diffusion
f cannabis began generally much later in the 1960s (although
o statistical data source is available) and did not reach the same
evel as in the USA, but it generally started to be considered as a
ublic health concern in the 1970s, at the same time as in the USA
Nahas & Greenwood, 1974).
In spite of these historical facts, quantitative data about the
ong-term history of cannabis use at the country level are scarce.
he EMCDDA has produced several reports showing that lifetime
revalence in the adult population trended upward in many Euro-
ean countries during the 1990s until year 2005 (EMCDDA, 2011, p.
3), and the same pattern occurred as well in the adolescent popu-
ation (Hibell et al., 2012, p. 13). But very few countries had reliable
eneral population surveys on drug use before 1990 (Hartnoll,
995), which led to public policies based on dubious statistics
ccording to some researchers (Sutton & Maynard, 1993). The ﬁrst
eneral population surveys on cannabis use took place in the 1970s
n Switzerland (Fahrenkrug, Rehm, Müller, Klingemann, & Linder,
995), in 1975 in the USA (Volkow, 2005), in 1980 in Germany
Gesundheitsforschung, 1983), and in the 1990s in France (Beck,
006). A chart of the evolution of cannabis use in the last 12 months
mong 15–34 year-olds in most European countries can be viewed
n the EMCDDA website (http://www.emcdda.europa.eu/stats13).
t is worth mentioning that some school surveys on drug use have
een carried out earlier than the general population surveys (in
weden, the ﬁrst annual school survey by the Swedish Council
or Information on Alcohol and other Drugs (CAN) took place
n 1971: http://www.emcdda.europa.eu/publications/country-
verviews/se).
In France, the proportion of lifetime users in the general popula-
ion grew continuously from 13% in 1992 (ﬁrst year of monitoring)
o 33% in 2010 (Beck, Guignard, Richard, Tovar, & Spilka, 2011). In
ermany, the 12-months prevalence among 18–24 year-old males
ncreased from 7.4% in 1980 to 26% in 2003 and decreased thereafter
o 17.5% in 2012. Similar trends were found for 25–39 year-olds but
t a lower level (Kraus, Pabst, Piontek, & Gomes de Matos, 2013).
n the USA, the proportion of young adults aged 18–25 who had
ver used cannabis was 5.1% in 1965, but increased steadily to 54%
n 1982. The lifetime use among 16–34 year-olds was estimated
t 51.6% in 2010 (EMCDDA, 2011) while the lifetime prevalence
mong 12th graders was 48% in 1975, reached a ﬁrst peak in
979 (58%), and recently declined slightly (49% in 2012) (Johnston,
’Malley, Bachman, & Schulenberg, 2013).
In most cases, consumption remains experimental or occasional
Vicente et al., 2008). Particular patterns of use, however, were
ound to be associated with a range of adverse effects that can
e categorized as acute, chronic or long-term, and the risk for
eveloping problems is increased when initiation takes place early
Behrendt, Wittchen, Hoﬂer, Lieb, & Beesdo, 2009; Chen, Storr,
 Anthony, 2009; de Graaf et al., 2010; Fergusson & Horwood,
006). An increasing prevalence of cannabis use may  imply that
he number of users experiencing adverse consequences on mental
nd physical health or on a social level will increase. Further-
ore, cannabis use can lead to legal prosecution in many countriesDrug Policy 25 (2014) 1103–1112
(even where alternatives to punishment are available for simple
use).
Cannabis experimentation is relatively common but regular
cannabis use is concentrated in the less afﬂuent social groups: stud-
ies show that the lower social classes, the unemployed, and the least
educated groups have a higher risk of becoming heavy cannabis
users, although the experimentation may  be a shared experience in
all social groups. This disparity in regular use has been shown in the
adolescent population (Korhonen et al., 2008; Legleye, Beck, Khlat,
Peretti-Watel, & Chau, 2012; Mayet, Legleye, Chau, & Falissard,
2011) as well as in the adult population (Compton, Conway, Stinson,
Colliver, & Grant, 2005; Legleye, Beck, Peretti-Watel, & Chau, 2008;
Piontek, Kraus, Pabst, & Legleye, 2011). In France, the legal prob-
lems with cannabis are concentrated among the poorest groups of
users who  are visible and exposed to police activity, as shown by
the comparison of police activity reports and data from the gen-
eral population surveys (Obradovic, 2012; Peretti-Watel, Beck, &
Legleye, 2004). The cannabis market changed recently with the
development of home-grown cannabis in Europe (Ben Lakhdar &
Weinberger, 2009; EMCDDA, 2008). This trend also induces a divide
between people who can grow cannabis at home (that requires
space and equipment) and avoid the problems related to cannabis
purchase on the market (whether with the police or the dealers)
and others. All these ﬁndings show that cannabis may  contribute
to social and health inequalities.
A problem in studying these inequalities comes from the lack
of data regarding the association of socioeconomic status and
cannabis use across generations. In contrast, since the seminal
work by Lopez, Collishaw, and Piha (1994), a consequent litera-
ture has developed about the tobacco (mostly cigarette) epidemic
in developed countries as well as in other parts of the world (Thun,
Peto, Boreham, & Lopez, 2012). The tobacco epidemic conceptu-
alizes variations in the age, educational and gender patterns in
smoking behaviour (Lopez et al., 1994; Platt, Amos, Gnich, & Parry,
2003). It ﬁts very well into the conceptual framework of the dif-
fusion of innovations in societies (Rogers & Shoemaker, 1971):
higher socioeconomic groups lead the way  and lower socioeco-
nomic groups follow. Following this pattern, smoking prevalence
rises and declines ﬁrst within the population groups that are at
the forefront of experimentation and at the same time most sen-
sitive to messages regarding the risks of tobacco. In the last stage,
smoking is likely to become limited to the groups who adopted it
relatively late in the diffusion process. Many European countries
have reached the last stage of this epidemic and therefore display
persistent or widening socioeconomic differences in relation to
smoking at the same time declining prevalence of smoking occurs
in the population as a whole (Huisman, Kunst, & Mackenbach,
2005). The literature shows a trend toward widening inequalities in
cigarette smoking at this last stage of the epidemic in many devel-
oped countries (Federico, Costa, & Kunst, 2007; Harman, Graham,
Francis, & Inskip, 2006; Legleye, Khlat, Beck, & Peretti-Watel, 2011;
Smith, Frank, & Mustard, 2009) or at least a persistence of educa-
tional disparities (Pampel, 2009).
The comparison of cannabis and tobacco may  not seem straight-
forward, since tobacco is a legal product and cannabis is not. There
are nevertheless similarities. For decades, developed countries
tried to ﬁght tobacco consumption, and many specialists qualify
tobacco as a denormalized or stigmatized product (Alamar & Glantz,
2006; Bayer, 2008; Chapman & Freeman, 2008; Peretti-Watel,
Legleye, Guignard, & Beck, 2013; Peretti-Watel, Legleye, Guignard,
& Beck, 2014). Due to the rise of cigarette prices, smuggling and
black market activities increased (Ben Lakhdar, 2008; Guindon,
Driezen, Chaloupka, & Fong, 2014). Additionally, cannabis users
frequently mix  cannabis with tobacco when smoking: this shared
route of administration via inhalation may  play an important role
in the association of the two  substances (Agrawal & Lynskey, 2009;
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grawal, Madden, Bucholz, Heath, & Lynskey, 2008) and there is
vidence that the use of one substance increases the risk of using
he other (Mayet, Legleye, Chau, & Falissard, 2010; Mayet et al.,
011; Timberlake et al., 2007). In parallel, there are some changes
n the regulation of cannabis, with 19 states and DC legalizing med-
cal cannabis use and two states legalizing recreational use in the
SA in the last years and an ongoing debate about depenalization
f cannabis in the USA (C-SPAN, 2013) as well as in other countries
ike France and Switzerland. We  are thus interested in the follow-
ng questions: is there a process of change in cannabis use that is
omparable to the tobacco epidemic? Do the social inequalities in
annabis smoking follow the same trend of a shifting educational
radient across generations? To answer these questions, we  exam-
ne cross-national data from three countries that may  be at different
tages of a potential cannabis epidemic.
ata
The data come from three general population surveys: (1) the
rench Health Barometer 2010, a representative nationwide tele-
hone survey of the non-institutionalized population aged 15–85
ears (Beck et al., 2011), (2) the 2009 German Epidemiologi-
al Survey of Substance Abuse, a representative survey of the
erman-speaking non-institutionalized civilian population aged
8–64 years that uses a mixture of paper, telephone, and inter-
et questionnaires (Kraus & Pabst, 2010) and (3) the 2010 U.S.
ational Survey of Drug Use and Health, a representative nation-
ide survey of individuals ages 12 years and older in the civilian,
on-institutionalized population that combines CAPI (computer-
ssisted personal interviewing, in which the interviewer reads the
uestions) and ACASI (audio computer-assisted self-interviewing)
SAMSHA, 2011). For the population studied here, men  and women
t ages 18–64 years with completed education and cannabis exper-
mentation data, the sample sizes equal 21,818 in France, 7887 in
ermany and 37,005 in the United States.
In France, the survey used a two-stage simple random sam-
le: household (with random digital dialling and including mobile
nd internet phones) and then one person within the household
Fig. 1. Cumulative proportion of cannabis experimenters (Y-axis) acDrug Policy 25 (2014) 1103–1112 1105
(Kish, 1949). The response rate was 60.5%. Weights adjust for survey
design, non-response and the proportion of mobile phones, using a
calibration process based on age, sex, diploma, employment status
and region to match the distribution of the last national Labor Force
Survey. In Germany, the survey used a two-stage probability samp-
ling, ﬁrst selecting communities proportional to population size
and second selecting individuals from residents’ registration ofﬁce.
The design over-sampled younger birth cohorts. The response rate
was 50.1%. Weights adjust for the sampling design and the national
distribution of age, gender, federal state, and size of the community.
In the United States, the survey used a stratiﬁed multistage pro-
cedure that oversamples youth and young adults. The response rate
was 74.6%, and weights account for selection probability and non-
response. Due to conﬁdentiality concerns, the public use NSDUH
data for the USA reports age in the following categories rather than
the exact age: 18–20, 21–25, 26–34, 35–44, 45–49, and 50–64 years.
These categories correspond to three broad age groups of 18–34,
35–49, and 50–64 years used in the analysis, but were recoded
within the age groups to the midpoints of 19, 23, 30, 40, 47, and 57.
Statistical analysis
Measures
The outcome variable was  age at ﬁrst use of cannabis (i.e.
age at experimentation). The independent variables were: gender,
age at data collection, educational level, national citizenship and
being native born. The categorization of educational level followed
the International standard classiﬁcation of education – ISCED –
(UNESCO, 2005): (1) ISCED 0, 1, 2 (low): lower secondary education
or less; (2) ISECD 3, 4 (medium): upper secondary education and
post-secondary non-tertiary education; (3) ISECD 5B (high-short):
ﬁrst level of tertiary education; (4) ISCED 5A and over (high-long):
tertiary education, upper level.We  chose education rather than occupation as an indicator of
social position for the following reasons: (1) it is generally more
accurately reported in survey questionnaires; (2) it is independent
from workforce involvement, therefore available for both genders
cording to age (X-axis) by sex, in three birth cohorts (France).
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qually; (3) it is acquired early in life in most cases, more stable over
he life course than occupation or income, and therefore less sen-
itive to the effects of selection mechanisms (Araya, Lewis, Rojas,
 Fritsch, 2003); and (4) it is the most robust indicator for social
osition linked to tobacco smoking (Cutler & Lleras-Muney, 2010).
We considered one life period, from age 11 to current age
t data collection or to age at cannabis experimentation (non-
xperimenters are censored) if these ages were below 35, as almost
ll experimentation (i.e. ﬁrst uses) occurs before this limit (Vicente
t al., 2008). Three birth cohorts were compared: 1936–1950,
951–1975 and 1976–1992, i.e. people aged 18–34, 35–49 and
0–64 years at the time of data collection. Years of observation
rom age 11 until age of eventual experimentation will be called
ears of follow-up hereafter.
ata analysis
Cannabis experimentation patterns by cohort group and gen-
er are described using 18 graphs focusing on the age span 11–34
ears in Figs. 1–3: each presents the cumulative proportions of
xperimenters by age and educational levels for one country.
Table 1 presents the sociodemographic structure of each
ational sample. Multivariate time-discrete logistic regression
Allison, 2010) is used to model age at cannabis experimentation in
ach country, for each gender and birth cohort, with data for non-
xperimenters being right-censored (Tables 2–4). The covariates
re: age at data collection, years of follow-up, years of follow-up
quared (capturing the “S” shape of the curves in Figs. 1–3), and the
SCED-derived educational level.
As tracking the trends in educational gradients requires equiva-
ent measures across age groups (Harman et al., 2006), we compute
idit scores (Bross, 1958) to produce a relative index of inequality
RII) for our ISCED-derived variable (Mackenbach & Kunst, 1997)
n each cohort and for each gender separately, following (Hayes &
erry, 2002). The ridit assigns to each individual the proportion of
he overall sample that has a higher education plus half of the pro-
ortion having the same educational level. The ridit is therefore a
ontinuous (linearized) measure of relative education ranging from
 to 1 (0 and 1 excluded) that takes into account the full distribu-
ion of education. Individuals in the lowest educational group (low)
ave the highest score, and individuals in the highest educational
roup (high-long) have the lowest score. The RII is the odds-ratio of
he ridit. In order to provide more common measures of the effect of
ducation, the classical OR of the lowest/highest educational group
s also provided in the tables. Gender ratios for each educational
evel are estimated by computing odds ratios for the interaction
etween gender and ridit for educational level.
All analyses were carried out using SAS V9.3.2 and Stata V11.
esults
Table 1 shows that the prevalence of cannabis experimentation
n the full sample is much higher in the USA (52.0%) than in France
32.8%) or Germany (27.9%). It is also almost stable in the USA across
eneration: it reaches 48.6% among 50–64 year-olds, 52.7% among
5–49 year-olds and 52.2% among 18–39 year-olds. By comparison,
he prevalence in Germany and especially in France shows a very
teep slope: from 13.2% in the oldest generation to 36.9% in the
ast generation in Germany and from 13.4% to 50.8% in France. In
his latter country, the prevalence among men  is even higher than
n the USA (59.7% vs 56.2%). It also shows that the education level
s higher in the USA than in France or Germany, except in the last
eneration in which the schooling process is not complete.
Figs. 1–3 show that in each country, the diffusion of cannabis
xperimentation follows an S-shaped curve for each gender and
eneration (this pattern is common to diffusion processes of Ta
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IFig. 2. Cumulative proportion of cannabis experimenters (Y-ax
onsumer goods). One ﬁrst well-known result is that the cumula-
ive proportion of experimenters is higher in males than in females
t each age and that the proportion of experimenters increases
cross generations in each country. This is true for all educational
evels and both genders, with the exception that experimentation
hows a small decline between the oldest and the middle genera-
ions for the most educated in the USA. The second result is that in
he older generation, the most educated people more often report
annabis experimentation than the least educated. On the contrary,
n the middle generation and more markedly in the younger gen-
ration, this educational gradient tends to be reversed.
There are nevertheless differences across countries and genders.
n each country, women are somewhat late in experimentation
Fig. 3. Cumulative proportion of cannabis experimenters (Y-axis) aording to age (X-axis) by sex, in three birth cohorts (Germany).
compared to men. In France, the reversal in educational gradient
is complete among males in the younger generation whereas it is
still incomplete among females. In the USA, the shift among males
is more pronounced and even visible in the oldest generation: the
most educated men  were in the second upper position in the old-
est generation, were already at the bottom (especially before age
25) in the middle generation and were clearly at the bottom in the
youngest generation. The most educated women  were on top in
the oldest generation, still in the top curves in the middle gen-
eration and only slightly lower than the others in the youngest
generation (especially before age 25). In Germany, the pattern is
somewhat different since there is no shift in the educational gradi-
ent but a convergence of the curves: the most educated are always
ccording to age (X-axis) by sex, in three birth cohorts (USA).
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Table 2
Time-discrete logistic regression of cannabis experimentation in France across generations (odds ratios and 95% conﬁdence intervals).
Men  Women  Gender ratio
OR 95% CI OR 95% CI OR 95% CI
50–64 years old
RII 0.66 0.46 0.94 0.05 0.03 0.09
Age  (in 2010) 0.89 0.87 0.91 0.89 0.87 0.91
Follow-up 1.84 1.67 2.01 1.96 1.76 2.18
Follow-up2 0.97 0.97 0.98 0.97 0.97 0.98
Men  (ref = women) 1.57 1.37 1.81
Men  × Ridit 12.53 6.37 24.65
OR  (lowest/highest educ) 0.57 0.44 0.75 0.12 0.09 0.17
35–49  years old
RII 0.95 0.76 1.18 0.41 0.31 0.54
Age (in 2010) 0.95 0.93 0.96 0.96 0.94 0.97
Follow-up 2.21 2.09 2.34 1.86 1.75 1.97
Follow-up2 0.96 0.96 0.96 0.97 0.97 0.97
Men  1.85 1.71 2.00
Men  × Ridit 2.26 1.59 3.20
OR  (lowest/highest educ) 0.95 0.79 1.14 0.50 0.40 0.62
18–34  years old
RII 1.49 1.23 1.80 0.61 0.48 0.77
Age  (in 2010) 0.99 0.98 1.00 0.97 0.96 0.98
Follow-up 2.91 2.71 3.13 3.21 2.95 3.50
Follow-up2 0.94 0.93 0.94 0.93 0.93 0.94
Men  1.67 1.56 1.79
0.7
o
g
t
a
m
T
TMen  × Ridit 
OR  (lowest/highest educ) 1.41 1.18 1.67 
n top, but the gap with the least educated tends to reduce across
enerations.The multivariate analysis conﬁrms these results. In the USA,
here is a complete reversal in the educational gradient in men
nd women, while in France the reversal is only complete among
en, and still on-going among women of the youngest generations.
able 3
ime-discrete logistic regression of cannabis experimentation in Germany across generat
Men  Wo
OR 95% CI OR
50–64 years old
RII 0.29 0.15 0.57 0.1
Age  (in 2010) 0.90 0.86 0.94 0.8
Follow-up 2.06 1.68 2.54 1.6
Follow-up2 0.97 0.96 0.98 0.9
Men  
Men  × Ridit 
OR  (lowest/highest educ) 0.25 0.09 0.70 0.2
35–49 years old
RII 0.43 0.27 0.68 0.4
Age  (in 2010) 0.95 0.92 0.98 0.9
Follow-up 1.40 1.25 1.56 1.6
Follow-up2 0.99 0.98 0.99 0.9
Men  
Men  × Ridit 
OR  (lowest/highest educ) 0.49 0.27 1.06 0.5
18–34 years old
RII 1.05 0.74 1.49 1.0
Age  (in 2010) 1.00 0.97 1.01 0.9
Follow-up 2.61 2.20 3.09 2.0
Follow-up2 0.95 0.94 0.96 0.9
Men  
Men  × Ridit 
OR  (lowest/highest educ) 0.97 0.73 1.11 1.02.19 1.62 2.96
0 0.57 0.84
In France, cannabis experimentation is overwhelmingly concen-
trated among the most educated women  in the older generation
(RII = 0.05) and the RII for women is lower for each generation
than the corresponding one for men, but also lower than the cor-
responding one in the USA. In the younger generation, cannabis
experimentation is slightly concentrated among the least educated,
ions (odds ratios and 95% Conﬁdence intervals).
men  Gender ratio
 95% CI OR 95% CI
7 0.07 0.42
9 0.84 0.94
1 1.25 2.06
8 0.97 0.99
2.37 1.79 3.14
1.78 0.59 5.36
3 0.08 0.64
0 0.24 0.65
3 0.90 0.96
6 1.44 1.91
8 0.97 0.98
1.57 1.31 1.87
1.11 0.57 2.19
7 0.32 1.05
6 0.73 1.54
9 0.98 1.01
2 1.74 2.35
6 0.95 0.97
1.43 1.29 1.58
1.03 0.67 1.58
1 0.73 1.40
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Table  4
Time-discrete logistic regression of cannabis experimentation in the USA across generations (odds ratios and 95% Conﬁdence intervals).
Men  Women  Gender ratio
OR 95% CI OR 95% CI OR 95% CI
50–64
RII 0.77 0.60 0.99 0.37 0.29 0.49
Age  (in 2010)a
Years of follow-up 1.91 1.78 2.05 1.84 1.71 1.98
Years  of follow-up2 0.96 0.96 0.97 0.97 0.96 0.97
Men  (ref = women) 1.53 1.39 1.69
Men  × Ridit 2.09 1.46 3.00
OR  (lowest/highest educ) 0.87 0.69 1.09 0.36 0.26 0.48
35–49
RII  1.24 1.06 1.45 0.78 0.67 0.92
Age  (in 2010)b 1.03 1.02 1.05 1.04 1.02 1.05
Years  of follow-up 1.60 1.53 1.67 1.54 1.48 1.60
Years  of follow-up2 0.97 0.97 0.97 0.97 0.97 0.97
Men  (ref = women) 1.31 1.23 1.39
Men  × Ridit 1.58 1.27 1.98
OR  (lowest/highest educ) 1.13 0.97 1.31 0.73 0.62 0.85
18–34
RII  1.38 1.26 1.51 1.24 1.13 1.36
Age  (in 2010)c 1.00 0.99 1.01 0.99 0.99 1.00
Years  of follow-up 2.02 1.95 2.09 2.05 1.98 2.13
Years  of follow-up2 0.95 0.95 0.95 0.95 0.95 0.95
Men  (ref = women) 1.25 1.21 1.30
Men  × Ridit 1.10 0.97 1.26
OR  (lowest/highest educ) 1.37 1.26 1.50 1.22 1.10 1.32
RII: relative index of inequality.
a Subjects coded to one age value: 57.
b Subjects coded to two age values: 40 or 47.
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cSubjects coded to three age values: 19, 23, or 30.
ithout gender differences in the USA (RII = 1.38 among men, 1.24
mong women), whereas in France, it is clearly concentrated in the
east educated men  (RII = 1.49) but still concentrated in the most
ducated women (RII = 0.61). The gender ratios decrease across
enerations in the USA (1.53, 1.31 and 1.25 in the younger one)
hile they tend to increase in France (1.57, 1.85 and 1.67 in the
ounger one). In the USA, cannabis experimentation is thus almost
s common among women  as among men, whereas it is still a
redominantly male behaviour in France.
These interpretations are conﬁrmed by the OR for the cross-
roduct gender × ridit that compares the males to the females
mong the least educated group. In the USA, the difference between
he least educated men  and women declines slowly across gener-
tions to statistical insigniﬁcance in the younger generation (2.09,
.58, 1.10) while it declines sharply between the older and the mid-
le generation and remains stable after a while in France (12.53,
.26, 2.19). The educational disparities are thus more pronounced
mong men  than women in France.
In Germany, a similar but less pronounced pattern of shift in
he educational gradient across generations is found, with a strict
arallel evolution of the educational gradient in men  and women,
eading to an RII estimate in the younger generations not signiﬁ-
antly different from 1 for both genders (RII = 1.1). The effects of
ducation are similar for both genders in each generation, as con-
rmed by the non-signiﬁcant values of the OR associated with
he interaction variable. In this country, cannabis use involved
xperimentation by the most educated groups in the past, but
xperimentation is now relatively homogeneously spread in the
oungest generation. In parallel, the gender ratio decreases con-
inuously across generations, from 2.37 to 1.43. This latter trend is
lose to the one observed in the USA.Discussion
Summary of ﬁndings
This study provides an insight into the dynamics of the dif-
fusion of cannabis experimentation in three western countries
(France, Germany, USA) through the use of random nationwide
representative general population surveys collected in 2009–2010.
We  investigated three generations of men  and women  aged 18–34,
35–49, 50–64 years (born in 1945–1960, 1961–1975, 1976–1992).
Considering the rise in educational levels over time, we used a
synthetic measure of the educational gap by way of the ridit, and
estimated gender ratios within the different cohorts. The analysis
is based on the reported age at ﬁrst cannabis use.
We found a complete reversal of the educational gradient across
generations for men  and women in the USA, but compared to
men, the reversal is delayed by one generation among women. In
Germany, there is a partial reversal of educational gradient, with
parallel timing for both genders: in the most recent generation, for
each gender, cannabis experimentation is equally shared by people
of all educational levels. In France, the complete reversal of gradi-
ent among men  is similar to the one observed in the USA, but only a
partial one among women: in the most recent generation, cannabis
experimentation among women  is still more frequent among the
most educated. Men  are overrepresented among the experimenters
in the three countries, but the patterns of evolution differ: in
Germany and in the USA, there is a slow convergence between gen-
ders, while differences are stable and more pronounced in France.
These results provide support to the hypothesis of a cannabis
epidemic that shares many features with the tobacco epidemic: it
begins in the most educated groups and among men, with women
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dopting later and reaching a lower level of prevalence. Following
his model, France seems to be at an earlier stage of the cannabis
pidemic compared to Germany and the USA, especially in regard
o gender differences.
One major difference with the model of the tobacco epidemic is
he prevalence of cannabis experimentation does not decline across
enerations, and does not decline among the most educated groups
except in the USA between the oldest and the middle generation).
nstead, it rises continuously in males, females, and all educational
evels. However, this does not mean that cannabis use is on the
ise in the same proportion across groups. In fact, the evolution of
he distribution of current cannabis use may  follow and reinforce
he trend towards the shift in educational gradient that we  found
or experimentation. Almost all studies in the drug ﬁeld show that
egular cannabis use (and more markedly intensive, problematic
se including dependence) is more frequent among people with
ow socioeconomic status or low education. Despite the fact that
annabis experimentation may  be more common in the afﬂuent
ocial backgrounds, adolescents from these families are less prone
o become daily or problematic users than the others. Cannabis
nd tobacco are similar from this point of view in adolescent sur-
eys (Legleye et al., 2012; Legleye, Janssen, Beck, Chau, & Khlat,
011a), while tobacco is more and more concentrated among the
oor in developed countries (Peretti-Watel, Seror, Constance, &
eck, 2009), However, these goods also share social utilities and
re intentionally used to enhance some moments and interactions.
Additionally, we found that the slopes of the curves of cumula-
ive experimentation were steeper in the youngest generation: the
R for the years of follow-up, which represents the mean increased
isk of being an experimenter for one additional year of age, were
igher in the youngest cohort than in the other two, providing
vidence that experimentation started at a younger age in recent
ears.
nterpretation of the ﬁndings
That the highest prevalence of experimentation switches from
igh to low education may  be related to the theory of innova-
ion (Rogers & Shoemaker, 1971): one may  think that the product
ay  have lost its appeal because it became more and more popu-
ar across time. In other words, cannabis may  have lost its power
f distinction (Bourdieu, 1979). The initial leaders in cannabis use
ho were the most educated groups may  thus have preferred to
se other drugs or to endorse other habits or attributes of cultural
eadership. But this switch may  reﬂect a change in the perception of
ealth hazard of cannabis use by the most educated, in accordance
ith what has been documented for tobacco. Indeed, the hazard of
annabis smoke has been studied more extensively in recent years
nd emphasized in prevention campaigns.
The consequence of this shift is a potential rise in inequali-
ies related to cannabis use, with low-educated groups being more
xposed to cannabis experimentation that may  be followed by dele-
erious health and psychosocial consequences: increased risk of
ater abuse and transition to other drugs, psychosocial maladap-
ation in case of abuse, and possible long-term respiratory harm.
ut this depends on the trajectories of use, a topic that is beyond
he scope of this work.
One question raised by our study relates to the interpretation of
ifferences between countries. First, although starting at different
evels of cannabis experimentation (with the USA showing a much
igher prevalence than France and Germany over past decades),
he trend of the association with educational level is similar in the
hree countries, with cannabis increasingly concentrated among
he least educated groups. However, there are strong disparities in
erms of gender ratios: the USA offers the most balanced situation,
ollowed by Germany, whereas cannabis experimentation is still aDrug Policy 25 (2014) 1103–1112
male behaviour in France. This contrasts with the fact that in the
recent generation, the prevalence of cannabis experimentation in
France is as high as in the USA. The gender ratio is thus neither
directly linked to the level of experimentation nor to the timing of
the diffusion of experimentation, as France and Germany present
similar prevalence rates for experimentation in the oldest cohort. It
seems to be linked to the dynamic of diffusion, as cannabis exper-
imentation is diffusing more rapidly in France than in Germany,
while levels are stable in the USA over two  generations. Using a ter-
minology used in economics, the cannabis market may be far from
equilibrium in France and, to a lesser extent, in Germany, compared
to the USA. Things may  change in the future, as the gender ratio for
experimentation at age 16 in the latest 2011 ESPAD school survey
(Hibell et al., 2012, p. 89) suggests that experimentation in France is
very high but gender balanced (39% for both genders, with a gender
ratio of 1.0), followed by the USA (38% for boys, 31% for girls with a
gender ratio of 1.2) and Germany (24% and 15% respectively, with
a gender ratio of 1.6).
Cannabis regulations differ between the three countries but
despite national and regional differences, the results of this study
point out that prevention campaigns should focus on the most vul-
nerable part of the population, either to prevent experimentation,
or more likely, to prevent transitions into more intensive use. The
results also emphasize that at-risks groups vary with the stage of
the diffusion process, as found for the tobacco epidemic.
That this pattern of diffusion may  apply to other illicit drugs
like cocaine and heroin and may  not be restricted to smokable psy-
choactive products raises a question for future investigations. The
addictive potential of recreational use may provide different results
for different drugs. This study nevertheless suggests that, despite
different legal status, cannabis and tobacco share some features in
their diffusion across generations and social groups.
Comparison with other studies
This is the ﬁrst cross-national study using this methodology and
one of the few assessing the long-term evolution of cannabis use
across populations, gender and educational groups. Recent publica-
tions on cannabis diffusion used different methodologies and were
only conducted in the USA (Kerr, Greenﬁeld, Bond, Ye, & Rehm,
2007; Miech & Koester, 2012) and Germany (Piontek et al., 2011).
They neither focused on educational differences nor offered such a
long retrospective time frame.
Limitations
Limitations of the ﬁndings relate to the cross-sectional data.
First, the self-reported retrospective measures of age of experi-
mentation may  be biased by recall error. Although retrospective
measures are generally found to be reliable for tobacco (Kenkel,
Lillard, & Mathios, 2003) and cannabis (Johnson & Mott, 2001;
Labouvie, Bates, & Pandina, 1997), differences in recall by age
could affect the cohort comparisons and more speciﬁcally the
least educated groups and ethnic minorities (Johnson & Mott,
2001). Second, the cross-sectional nature of the data makes it hard
to disentangle the causal relationships between education and
experimentation. Many youths experiment with cannabis before
completing their education, requiring longitudinal data to draw
causal conclusions about the relationship. It is clear, however, that
the association is strong and has changed in meaningful ways.
Third, the cross-sectional samples of the populations at older
ages exclude those who died at younger ages, a group dispropor-
tionately composed of smokers and those with less education.
Although differential mortality may  bias comparisons to the oldest
cohort, limiting the analysis to persons under age 65 years min-
imizes the problem. Fourth, the present data cannot separate the
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ndependent inﬂuence of age, period, and cohort. Analyses of these
ffects require combined consecutive cross-sectional surveys.
Fifth, the sample size of the German data was limited, in addi-
ion to the limited number of experimenters in the older cohorts.
ince cannabis use emerged later in East Germany than in West
ermany, especially among older cohorts, it may  lower the com-
ined prevalence. However this does not alter the overall pattern of
hange across generations. In the USA, the exact age of the individ-
als was unknown. However, the conﬁdence intervals are relatively
arrow and the OR for the inﬂuence of age was very small in all three
ountries, suggesting that these limitations had only a small effect
n the reliability of the results.
Finally, although differences in survey designs and data collec-
ion modes may  have inﬂuenced comparisons between national
revalence, the national patterns of evolution of cannabis use likely
re not affected by this potential bias. Additionally, differences in
revalence levels between the USA, France and Germany are con-
rmed by the results of recent school surveys (Hibell et al., 2012).
Compared to the age of onset of regular cigarette smoking that
as been studied in a similar way, cannabis experimentation may
ot be followed by regular use. We  cannot interpret our results as a
escription of cannabis use but rather as a description of the diffu-
ion of cannabis as a product in the population. However, as noted
bove, initiation and particularly early initiation is an important
redictor of future intensive use. The present data do not allow any
rojection of future cannabis use by cohort. We  could only infer
he future development of use by education based on the epidemi-
logical model assuming a declining trend. But the patterns of use
f cannabis and the similarity between tobacco and cannabis could
hange substantially with legalization of cannabis. In the United
tates, 19 states and DC have approved medical cannabis programs,
nd two states (Colorado and Washington) have legalized cannabis
or recreational use. The change in legal status of the drug could
ncrease prevalence level and reshape the educational gradient in
annabis use.
Future research is needed to study the evolution of the transition
o regular use of cannabis across generations.
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